Psychedelics and Neuroplasticity in Chronic Pain Healing

Chronic pain is often approached as a structural problem. Something in the body is wrong, and the task is to find it, diagnose it, and fix it.

And in some cases, that is accurate.

But many people live with pain that persists even when there is no clear ongoing injury, no structural damage, and nothing that fully explains the intensity or duration of what they are experiencing.

This is where a different understanding of pain becomes important.

Pain is shaped by the brain and nervous system

Pain is not a direct readout of tissue damage. It is an output of the brain, shaped by sensory input, past experience, emotional state, and context (Melzack, 1999).

Over time, particularly in chronic pain, the nervous system can become sensitised. Neural pathways associated with pain become more active and more easily triggered. The brain begins to predict pain, even in the absence of clear physical cause.

This is sometimes referred to as central sensitisation.

It means that pain is real, but it is being maintained by patterns in the nervous system rather than ongoing injury.

Neuroplasticity and chronic pain

Neuroplasticity refers to the brain’s ability to change and reorganise itself.

This includes the strengthening of certain neural pathways through repetition. In chronic pain, this can mean that pain pathways become more dominant over time, while pathways associated with safety and ease become less accessible (Apkarian et al., 2009).

The system learns pain.

And what is learned can, in theory, be unlearned.

Where psychedelics come in

Psychedelics such as psilocybin have been shown to increase neuroplasticity, both at a cellular level and across brain networks.

Research suggests that psychedelics promote synaptic growth, increase neural connectivity, and temporarily disrupt rigid patterns of brain activity (Carhart-Harris et al., 2014; Ly et al., 2018).

This creates a window of flexibility.

Patterns that have become fixed, including those associated with pain, may become more open to change.

Disrupting rigid patterns

In chronic pain, the brain can become locked into habitual patterns of prediction and response.

Psychedelics appear to reduce activity in the default mode network (DMN), a network associated with self-referential thinking and rigid patterns of perception (Carhart-Harris et al., 2012).

This disruption may allow for a temporary loosening of entrenched patterns, including those related to pain.

People often report changes in how they experience their bodies, sometimes describing a sense of distance from the pain, or a shift in how it is interpreted.

This does not mean the pain disappears completely.

But the relationship to it can change.

Emotional and psychological factors

Chronic pain is not only neurological. It is also influenced by emotional and psychological processes.

Unprocessed stress, trauma, and long-term tension can contribute to how the nervous system organises around pain (Lumley et al., 2011).

Psychedelics can increase access to emotional material that has been held outside of awareness. This can allow for processing and integration in a way that may reduce the overall load on the system.

This is not about “thinking your way out of pain”.

It is about changing the conditions that maintain it.

The importance of context and integration

The effects of psychedelics are not isolated to the substance itself. Set, setting, and integration all play a critical role in how these changes are stabilised.

Neuroplasticity creates a window of opportunity.

What happens within that window matters.

Without integration, the system can return to its previous patterns. With structured support, new ways of relating to the body and to pain can begin to stabilise.

A cautious but promising area

The research into psychedelics and chronic pain is still emerging.

Early studies suggest potential benefits for conditions such as fibromyalgia, migraines, and phantom limb pain, but more large-scale, controlled trials are needed (Schindler et al., 2015; Castaneda et al., 2020).

It is not a universal solution.

But it is an area that is beginning to offer a different perspective on how chronic pain can be approached.

If this resonates

If you are living with persistent pain that has not responded to traditional approaches, it may be worth exploring the role of the nervous system, neuroplasticity, and the body more broadly.

This does not replace medical care.

But it can offer another way of understanding what is happening.

🌿 If you are exploring chronic pain, nervous system work, or psychedelic-assisted approaches, I offer structured support across the UK through my three-arc Transform process.

👉 You’re welcome to book a free discovery call if you’d like to explore whether this work is right for you.

References

Apkarian, A. V., Baliki, M. N., & Geha, P. Y. (2009). Towards a theory of chronic pain. Progress in Neurobiology, 87(2), 81-97.

Carhart-Harris, R. L., et al. (2012). Neural correlates of the psychedelic state. PNAS, 109(6), 2138-2143.

Carhart-Harris, R. L., et al. (2014). The entropic brain. Frontiers in Human Neuroscience, 8, 20.

Castaneda, J., et al. (2020). Psychedelics and chronic pain: A review. Journal of Psychoactive Drugs.

Ly, C., et al. (2018). Psychedelics promote structural and functional neural plasticity. Cell Reports, 23(11), 3170-3182.

Lumley, M. A., et al. (2011). Emotional awareness and expression therapy for chronic pain. Pain, 152(6), 1235-1242.

Melzack, R. (1999). From the gate to the neuromatrix. Pain Supplement, 6, S121-S126.

Schindler, E. A. D., et al. (2015). Psychedelics and headache disorders. Current Pain and Headache Reports, 19(10), 1-9.